Mass General Brigham Innovation

Mandate and remit

What This Program Does

Mass General Brigham Innovation is the business development arm of the health system. Official pages state that the group is responsible for the worldwide commercial application of discoveries made by Mass General Brigham employees and that it coordinates industrial relationships and intellectual property management across Brigham and Women's Hospital, Massachusetts General Hospital, Mass Eye and Ear, McLean Hospital, and Spaulding Rehabilitation. The office reports responsibility for industry collaborations, venture investing, licensing, company creation, technology marketing, open innovation alliances, and workforce development. Official leadership materials identify Chris Coburn as Chief Innovation Officer and state that his team annually stewards $150 million of revenue, about 30 spin-offs, and nearly 300 licensing transactions, with a venture investment arm of nearly $500 million under management. Mass General Brigham Ventures is described as an early-stage venture firm founded in 2008. A separate Artificial Intelligence and Digital Innovation Fund, founded in 2020 with a $30 million commitment, invests in venture-stage companies aligned with system strategy.

Areas of Focus

Commercialization Pathways

These routes appear in the program's sourced public record.

Named Programs and Initiatives

• Mass General Brigham Innovation ↗

  System business development office for licensing, industry collaboration, company creation, venture investing, and innovator support.

• Mass General Brigham Ventures

  Early-stage venture capital firm founded in 2008 to advance life science technologies emerging from Mass General Brigham.

• Artificial Intelligence and Digital Innovation Fund

  Fund founded in 2020 with a $30 million commitment to invest in venture-stage companies whose offerings further Mass General Brigham strategic initiatives.

• World Medical Innovation Forum

  Official forum convening industry executives, investors, clinicians, scientists, entrepreneurs, and government officials around medical innovation.

• MESH Healthcare Innovation Bootcamp

  Official innovation course of Mass General Brigham described in the Innovator's Commercialization Guide as an inventor-built course for clinicians and researchers.

Venture Investment and Company Creation

Technology Transfer, Intellectual Property, and Licensing

• Licensing of medical technologies

  Official pages state that Innovation licenses medical technologies in diagnostics, medical devices, research tools, medical software, therapeutics, and vaccines.

Startups, Spinouts, and External Offerings

• Annual spin-off activity

  The official CIO biography states that the business development group annually stewards about 30 spin-offs. A complete current company list was not published on the pages reviewed.

Publicly Reported Outcomes

• Reported annual commercialization activity

  Official leadership materials state that the group annually stewards $150 million of revenue, about 30 spin-offs, and nearly 300 licensing transactions.

Leadership and Structure

Organizational home: Mass General Brigham Innovation, Mass General Brigham

• Chris Coburn — Chief Innovation Officer Official biography ↗

Contact the Program

Use the program's published contact route for partnership, licensing, innovation, or program inquiries.

Program email

innovation@mgb.org

Official contact page

Open contact page ↗

Related Programs

Comparable records based on shared public taxonomy, location, or commercialization route.

Sources and Updates

Reviewed August 30, 2026. External source links open in a new tab.

1. Innovation | Mass General Brigham ↗ — Mass General Brigham. Accessed August 30, 2026.
2. About Mass General Brigham Innovation ↗ — Mass General Brigham. Accessed August 30, 2026.
3. Chris Coburn, Chief Innovation Officer ↗ — Mass General Brigham. Accessed August 30, 2026.
4. Innovator's Commercialization Guide ↗ — Mass General Brigham Innovation. Accessed August 30, 2026.